1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone,
ADX71149,
JNJ-40411813,
JNJ-40411813,
1127498-03-6,
ADX-71149,
JNJ40411813,
JNJ 40411813,
UNII-612BYT76F3,
CHEMBL3337527,
612BYT76F3,
ADX71149,
2(1H)-Pyridinone, 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-,
1-Butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone,
1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-2(1H)-Pyridinone,
1'-Butyl-3'-chloro-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2'-one,
1'-Butyl-3'-chloro-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-(1,4')bipyridinyl-2'-one,
HYOGJHCDLQSAHX-UHFFFAOYSA-N,
GTPL8946,
SCHEMBL1035416,
1-butyl-3-chloro-4-(4-phenylpiperidin-1-yl)pyridin-2-one,
BCP23709,
ADX 71149,
BDBM50051408,
ZINC59047060,
AKOS030526260,
CS-3357,
DB12059,
SB16990,
NCGC00485897-01,
DA-15400,
HY-15748,
QC-10463,
FT-0752754,
A12909,
3-Chloro-1-butyl-4-(4-phenylpiperidino)pyridine-2(1H)-one,
1-butyl-3-chloro-4-(4-phenylpiperidin-1-yl)pyridin-2(1H)-one,
1'-Butyl-3'-chloro-4-phenyl-3,4,5,6-tetrahydro-2H,1 'H-[1,4']bipyridinyl-2'-one,
1'-Butyl-3'-chloro-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4]bipyridinyl-2'-one,
D03FZT,
MGluR2 modulator (oral, schizophrenia/anxiety), Johnson & Johnson,
Metabotropic glutamate 2 receptor modulator (oral, schizophrenia/anxiety), Johnson & Johnson,